Cybin Inc. (OTCMKTS:CLXPF - Get Free Report) was down 5.1% during mid-day trading on Tuesday . The stock traded as low as $8.33 and last traded at $8.45. Approximately 324,287 shares were traded during trading, a decline of 41% from the average daily volume of 551,962 shares. The stock had previously closed at $8.90.
Cybin Stock Performance
The stock has a fifty day moving average price of $7.04 and a 200-day moving average price of $8.31. The firm has a market capitalization of $1.29 billion and a PE ratio of -36.29.
Cybin Company Profile
(
Get Free Report)
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Read More
Before you consider Cybin, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cybin wasn't on the list.
While Cybin currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
